期刊文献+

参照NCCLS EP9-A2文件探讨实验室可用的试剂性能评估方案 被引量:1

Discussion on available reagent performance evaluation scheme according to NCCLS EP9-A2
下载PDF
导出
摘要 目的参照美国国家临床实验室标准化委员会(NCCLS)EP9-A2文件探讨实验室可用的试剂性能评估方案。方法选取3个不同厂家的高密度脂蛋白胆固醇测定试剂盒,进行性能评估实验并比较分析,观察其精密度、线性、抗干扰能力以及临床比对结果。结果 3个不同厂家试剂盒的批内精密度和线性比较,差异无统计学意义(P>0.05),抗干扰能力选择性清除法最优,三者间临床样本的测定结果相关性差。结论 3个不同厂家的高密度脂蛋白胆固醇测定试剂性能各有优劣,可满足临床基本需求。各实验室可根据自身需求选择不同的方法。 Objective To discuss the available reagent performance evaluation scheme according to NCCLS EP9-A2. Methods The determined reagent of high-density lipoprotein cholesterol ( HDLC ) produced by 3 different manufactories were selected for conducting the performance evaluation experiment and comparative analysis. Tile precision, linearity, anti-interference ability and clinical comparison results were observed. Results The intra-batch precision and linearity had no statistical difference among 3 reagent samples produced'by 3 different manufactories. The selective clearance method was best in the ability of anti-interference. The detected results of clinical samples had poor correlation among 3 reagents. Conclusion Each performance among 3 different methods has the advantages and disadvantages, and all of them can meet the clinical basic needs. Each laboratory should choose different methods according to oneself needs.
作者 耿汉科
出处 《现代医药卫生》 2013年第8期1168-1169,共2页 Journal of Modern Medicine & Health
关键词 胆固醇 HDL 实验室技术和方法 评价研究 直接测定法 选择性清除法 选择性抑制法 聚乙二醇酶修饰法 Cholesterol,tlDI, Laboratory techniques and procedures Evaluation studies Direct assay Selective clearance method Selective inhibition method Polyethylene glycol enzyme modification method
  • 相关文献

参考文献11

二级参考文献20

  • 1中华医学会检验学会血脂测定推荐方法四、血清高密度脂蛋白胆固醇测定法(草案)[J].中华医学检验杂志,1995,18(5):311-312. 被引量:38
  • 2中华医学会检验学会血脂测定推荐方法五、血清低密度脂蛋白胆固醇测定法(草案)[J].中华医学检验杂志,1995,18(6):381-382. 被引量:17
  • 3Wilson PW,Abbott RD,Castelli WP. High density lipoprotein cholesterol and mortality, the Framing- ham Heart Study[J]. Arteriosclerosis, 1988,8: 737- 741.
  • 4National Cholesterol Education Program. Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel Ⅱ )[J]. Circulation, 1994, 89:1330-1445.
  • 5[2]Warnick GR,et al.Dextran Sulfate-mg2+ Precipitation Procedure for guantitation of high density eipoprotein cholesterol proposed selected method.Chin Chem,1982,28:1379.
  • 6[3]Warnjck GR,Wood PD.National cholesterol education program recommendations for measurement of high-dinsity lipopotein diolesterol executive summary.Clin Chem,1995,41:1427-1433.
  • 7Parkard C,Casloke M,Shepherd J,et al.The role of small,dense low density lipoprote in(LDL):a new look[J].Int J Cardiol,2000,74(suppl 1):S17-22.
  • 8Vincent VM,Schiele F,Gueguen R,et al.Biological Variations and genetic reference values for apoliprotein E,Serum concentrations:results from the STANISLAS cohort study[J].Clin Chen,1998,44(5):957-965.
  • 9Oram JF.Tangier disease and ABCA1[J].Biochim Biophys Acta,2000,1529(1/3):321-330.
  • 10Brousseau ME,Bodzioch M,Schaefer EJ,et al.Common variants in the gene encoding ATP-binding cassette tranporter1 in men with low HDL cholesterol levels and coronary heart disease[J].Atherosclerosis,2001,154(3):607-611.

共引文献32

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部